AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 17 filers reported holding AZURRX BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $640,000 | -45.9% | 1,067,571 | +53.5% | 0.07% | -34.3% |
Q2 2019 | $1,182,000 | -29.8% | 695,504 | 0.0% | 0.11% | -29.4% |
Q1 2019 | $1,683,000 | +99.9% | 695,504 | 0.0% | 0.15% | +200.0% |
Q4 2018 | $842,000 | -18.1% | 695,504 | +73.9% | 0.05% | -23.9% |
Q3 2018 | $1,028,000 | -19.9% | 400,000 | 0.0% | 0.07% | -23.0% |
Q2 2018 | $1,284,000 | – | 400,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pensionmark Financial Group, LLC | 130,900 | $94,000 | 0.02% |
PARSONS CAPITAL MANAGEMENT INC/RI | 168,203 | $225,000 | 0.02% |
Merrion Investment Management Co, LLC | 14,000 | $18,000 | 0.02% |
Newman Dignan & Sheerar, Inc. | 23,915 | $32,000 | 0.01% |
HBW ADVISORY SERVICES LLC | 25,077 | $34,000 | 0.01% |
Traynor Capital Management, Inc. | 30,000 | $40,000 | 0.01% |
Virtu Financial LLC | 77,734 | $104,000 | 0.01% |
Waldron Private Wealth LLC | 69,835 | $93,000 | 0.01% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $134,000 | 0.00% |
Tower Research Capital LLC (TRC) | 156,120 | $209,000 | 0.00% |